• Regenerus Laboratories, a UK diagnostic health testing company, secured £8 million to fund operational scale-up and market expansion.
• Funding comprises a £5 million equity investment led by Foresight Group Holdings and a £3 million R&D grant from Scottish Enterprise.
• Capital targets expansion into the medical doctor channel, international logistics, product development, and commercialization of its digital diagnostics platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Foresight Group Holdings Ltd. published the original content used to generate this news brief on July 13, 2026, and is solely responsible for the information contained therein.